Results 41-60 of 8,500 for speaker:John Brady
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Certainly prior to that there were consultants there. I agree there is the potential for a huge conflict of interest, particularly where some consultants are not filling out their statutory declarations to SIPO. Essentially, I am not sure in all of the processes Mr. Sweeney has talked about that the proper safeguards are being adhered to and being implemented and I am really concerned...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: That was an overrun of €197,000. Is that figure correct?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: The integrated human resource and payroll system was-----
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: How did that fare? Was there an overspend there?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: A €2.8 million overspend.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Did Mr. Hanlon say there was no tender done on this?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: This is extraordinary. There was an overspend of €2.8 million. How much was the total spend on it?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Mr. Hanlon did not think it was applicable.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Why was that?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: That is extraordinary. Does Mr. Hanlon agree?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: It is significant.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I am sorry, Deputy Kenny, I will let you back in shortly. We need a lot more detail on this because the committee has embarked on a piece of work looking essentially at what amounts to mismanagement, poor oversight, poor due diligence and lack of processes, specifically on IT projects. This just follows on from a litany of other wastage of public money. That is what it is. What role did...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Is there someone else who might speak to that?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Who thought there was a derogation in place? How did that train of thought come about? I am not sure who might be able to answer that.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: So there were no processes and no tendering processes. Was a view sought from the Department or from the HSE?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: That was the HSE, and it said it was-----
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I find it extraordinary and it is an issue this committee will certainly return to. I have a number of other questions.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Thank you.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: If I may ask a question, the officials have come before the public accounts committee today. I am sure meetings took place among them as to what might be discussed here. Did they not think they should be forthcoming with information such as this, given that they were coming before the committee that is tasked with scrutinising public expenditure? Do they not think that should have been...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: It certainly will, and I think there will be a lot more information required from the hospital. I ask that we would get a briefing note from the hospital because we will have the HSE in before us next week and I think it is going to be critical to have all that information. I am trying to tie all the pieces together. As the C and AG said, there are governance issues in Beaumon going back...